Track topics on Twitter Track topics that are important to you
EMERYVILLE, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the planned resignation of Dr. Nam-Hai Chua and the designation of Bram Klaeijsen to serve as a member of Amyris's board of directors. Klaeijsen is a seasoned business leader from Cargill, Inc. ("Cargill") and has served in various roles with affiliates of Temasek Holdings ("Temasek"). Klaeijsen is expected to replace Dr. Chua on the board of directors, pursuant to Temasek's right to designate a director under an agreement among Temasek, Amyris and certain other investors on February 23, 2012.
"We are excited to welcome Bram as a designee to our Board of Directors and appreciate Temasek's continued commitment to Amyris by designating him," said John Melo, President & CEO of Amyris. "He has extensive global business leadership experience across a variety of key roles worldwide in the food and ingredients sectors and, in particular, as the President and Regional Director at Cargill Asia-Pacific. His deep experience will support our expanding role in several key global growth markets – including the Asia-Pacific region − where we are expanding with multiple growth opportunities as a leading provider of renewable products to the world's leading brands."
Continued Melo, "We'd also like to thank Dr. Chua for his service to Amyris since his appointment in 2012 to our board and the role he has played in helping to guide the company in its continued development and growth as a leader in its space. We wish him well in his pursuit of other professional commitments."
Klaeijsen is currently engaged as a corporate advisor with Temasek and has served on the boards of directors of several companies, including Cargill Tropical Palm Holdings Pte Ltd., a joint venture between Temasek and Cargill from 2010 through January 2015. Previously, he served as President and Regional Director, Asia-Pacific, and Platform Leader for Cargill Food Ingredients and Systems, a division of Cargill, from which he retired in January 2015. Klaeijsen joined Cargill in 1978 and held a number of leadership positions, including as Platform Leader for Cargill's European Food Ingredients businesses from 1999 to 2003, when he assumed the role of Executive Vice President of Cargill Food Ingredients and Systems. He held that position until he joined Cargill's Asia-Pacific operations in 2009, where he served until his retirement. Klaeijsen holds a Bachelor of Science degree in chemical engineering from technical college Breda in the Netherlands.
Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com.
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as expectations regarding board of director composition and the ability of Amyris to leverage its role as a provider of renewable products in order to achieve growth) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including, among other things, that Mr. Klaeijsen is ultimately not appointed to serve on the Board, and other risks detailed in the "Risk Factors" section of Amyris's annual report on Form 10-Q filed on May 5, 2015. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
Amyris is a registered trademark of Amyris, Inc.
CONTACT: Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 firstname.lastname@example.orgNEXT ARTICLE
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...